{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T18:56:29Z","timestamp":1778698589214,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Shenzhen High-level Hospital Construction Fund","award":["XKJS-PWK-001"],"award-info":[{"award-number":["XKJS-PWK-001"]}]},{"name":"Medical Science and Technology Research Foundation of Guangdong Province","award":["No.B2023229"],"award-info":[{"award-number":["No.B2023229"]}]},{"name":"Shenzhen Key Medical Discipline Construction Fund","award":["No.SZXK079"],"award-info":[{"award-number":["No.SZXK079"]}]},{"name":"Youth Fund of The Third People\u2019s Hospital of Shenzhen","award":["No. G2021003"],"award-info":[{"award-number":["No. G2021003"]}]},{"DOI":"10.13039\/501100017607","name":"Shenzhen Fundamental Research Program","doi-asserted-by":"crossref","award":["NO.JCYJ20210324131809027"],"award-info":[{"award-number":["NO.JCYJ20210324131809027"]}],"id":[{"id":"10.13039\/501100017607","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-10618-6","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:43:56Z","timestamp":1752137036000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Circ_0008043 promotes the metastasis of hepatocellular carcinoma by regulating the miR-661\/PLEKHG4B axis"],"prefix":"10.1038","volume":"15","author":[{"given":"Kangjun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taishi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"10618_CR1","doi-asserted-by":"crossref","unstructured":"Torimura, T. & Iwamoto, H. Treatment and the prognosis of hepatocellular carcinoma in Asia. LIVER INT 42 (2022). (2042).","DOI":"10.1111\/liv.15130"},{"key":"10618_CR2","doi-asserted-by":"crossref","unstructured":"Zhang, C. H., Cheng, Y., Zhang, S., Fan, J. & Gao, Q. Changing epidemiology of hepatocellular carcinoma in Asia. LIVER INT 42 (2022). (2029).","DOI":"10.1111\/liv.15251"},{"key":"10618_CR3","doi-asserted-by":"crossref","unstructured":"Ren, Z., Ma, X., Duan, Z. & Chen, X. Diagnosis, Therapy, and Prognosis for Hepatocellular Carcinoma. Anal Cell Pathol (Amst) 8157406 (2020). (2020).","DOI":"10.1155\/2020\/8157406"},{"key":"10618_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s11684-021-0848-3","volume":"15","author":"W Zhang","year":"2021","unstructured":"Zhang, W., Zhang, B. & Chen, X. P. Adjuvant treatment strategy after curative resection for hepatocellular carcinoma. Front. Med. 15, 155 (2021).","journal-title":"Front. Med."},{"key":"10618_CR5","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.2217\/fon-2020-0758","volume":"17","author":"PR Galle","year":"2021","unstructured":"Galle, P. R., Dufour, J. F., Peck-Radosavljevic, M., Trojan, J. & Vogel, A. Systemic therapy of advanced hepatocellular carcinoma. FUTURE ONCOL. 17, 1237 (2021).","journal-title":"FUTURE ONCOL."},{"key":"10618_CR6","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"Vogel, A., Meyer, T., Sapisochin, G., Salem, R. & Saborowski, A. Hepatocellular carcinoma. LANCET 400, 1345 (2022).","journal-title":"LANCET"},{"key":"10618_CR7","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.semcancer.2021.07.017","volume":"86","author":"GP Nagaraju","year":"2022","unstructured":"Nagaraju, G. P., Dariya, B., Kasa, P., Peela, S. & El-Rayes, B. F. Epigenetics in hepatocellular carcinoma. SEMIN CANCER BIOL. 86, 622 (2022).","journal-title":"SEMIN CANCER BIOL."},{"key":"10618_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.canlet.2021.02.004","volume":"505","author":"L Chen","year":"2021","unstructured":"Chen, L. & Shan, G. CircRNA in cancer: fundamental mechanism and clinical potential. CANCER LETT. 505, 49 (2021).","journal-title":"CANCER LETT."},{"key":"10618_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.molcel.2014.08.019","volume":"56","author":"R Ashwal-Fluss","year":"2014","unstructured":"Ashwal-Fluss, R. et al. CircRNA biogenesis competes with pre-mRNA splicing. MOL. CELL. 56, 55 (2014).","journal-title":"MOL. CELL."},{"key":"10618_CR10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.cca.2021.09.013","volume":"523","author":"M Zhang","year":"2021","unstructured":"Zhang, M. et al. circRNA-miRNA-mRNA in breast cancer. CLIN. CHIM. ACTA. 523, 120 (2021).","journal-title":"CLIN. CHIM. ACTA"},{"key":"10618_CR11","doi-asserted-by":"publisher","first-page":"945310","DOI":"10.3389\/fendo.2022.945310","volume":"13","author":"M Gao","year":"2022","unstructured":"Gao, M., Zhang, Z., Sun, J., Li, B. & Li, Y. The roles of circRNA-miRNA-mRNA networks in the development and treatment of osteoporosis. Front. Endocrinol. (Lausanne). 13, 945310 (2022).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10618_CR12","doi-asserted-by":"publisher","first-page":"12412","DOI":"10.18632\/aging.102580","volume":"11","author":"J Liu","year":"2019","unstructured":"Liu, J. et al. CircRNA_100367 regulated the radiation sensitivity of esophageal squamous cell carcinomas through miR-217\/Wnt3 pathway. Aging (Albany NY). 11, 12412 (2019).","journal-title":"Aging (Albany NY)"},{"key":"10618_CR13","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/s41419-020-03276-1","volume":"11","author":"G Huang","year":"2020","unstructured":"Huang, G. et al. CircRNA hsa_circrna_104348 promotes hepatocellular carcinoma progression through modulating miR-187-3p\/RTKN2 axis and activating Wnt\/beta-catenin pathway. CELL. DEATH DIS. 11, 1065 (2020).","journal-title":"CELL. DEATH DIS."},{"key":"10618_CR14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41417-020-00218-z","volume":"28","author":"W Zhang","year":"2021","unstructured":"Zhang, W., Liu, T., Li, T. & Zhao, X. Hsa_circRNA_102002 facilitates metastasis of papillary thyroid cancer through regulating miR-488-3p\/HAS2 axis. CANCER GENE THER. 28, 279 (2021).","journal-title":"CANCER GENE THER."},{"key":"10618_CR15","doi-asserted-by":"crossref","unstructured":"Han, J. et al. Clinicopathological-Associated regulatory network of deregulated circrnas in hepatocellular carcinoma. Cancers (Basel) 13, 2772 (2021).","DOI":"10.3390\/cancers13112772"},{"key":"10618_CR16","doi-asserted-by":"publisher","first-page":"6600","DOI":"10.1080\/21655979.2022.2044260","volume":"13","author":"K Zhang","year":"2022","unstructured":"Zhang, K. et al. Circular RNA circ_0008043 promotes the proliferation and metastasis of hepatocellular carcinoma cells by regulating the MicroRNA (miR)-326\/RAB21 axis. BIOENGINEERED 13, 6600 (2022).","journal-title":"BIOENGINEERED"},{"key":"10618_CR17","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1007\/s11010-022-04455-8","volume":"477","author":"KL Tong","year":"2022","unstructured":"Tong, K. L., Tan, K. E., Lim, Y. Y., Tien, X. Y. & Wong, P. F. CircRNA-miRNA interactions in atherogenesis. MOL. CELL. BIOCHEM. 477, 2703 (2022).","journal-title":"MOL. CELL. BIOCHEM."},{"key":"10618_CR18","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1146\/annurev-biochem-060308-103103","volume":"79","author":"MR Fabian","year":"2010","unstructured":"Fabian, M. R., Sonenberg, N. & Filipowicz, W. Regulation of mRNA translation and stability by MicroRNAs. ANNU. REV. BIOCHEM. 79, 351 (2010).","journal-title":"ANNU. REV. BIOCHEM."},{"key":"10618_CR19","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.molcel.2018.06.034","volume":"71","author":"X Li","year":"2018","unstructured":"Li, X., Yang, L. & Chen, L. L. The biogenesis, functions, and challenges of circular RNAs. MOL. CELL. 71, 428 (2018).","journal-title":"MOL. CELL."},{"key":"10618_CR20","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1093\/bib\/bbaa001","volume":"22","author":"L Chen","year":"2021","unstructured":"Chen, L. et al. The bioinformatics toolbox for circrna discovery and analysis. BRIEF. BIOINFORM. 22, 1706 (2021).","journal-title":"BRIEF. BIOINFORM"},{"key":"10618_CR21","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41392-020-00375-5","volume":"5","author":"J Xu","year":"2020","unstructured":"Xu, J. et al. CircRNA-SORE mediates Sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1. Signal. Transduct. Target. Ther. 5, 298 (2020).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10618_CR22","doi-asserted-by":"publisher","first-page":"8183","DOI":"10.18632\/aging.102312","volume":"11","author":"Y Su","year":"2019","unstructured":"Su, Y. et al. CircRNA Cdr1as functions as a competitive endogenous RNA to promote hepatocellular carcinoma progression. Aging (Albany NY). 11, 8183 (2019).","journal-title":"Aging (Albany NY)"},{"key":"10618_CR23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13046-020-1529-9","volume":"39","author":"XY Huang","year":"2020","unstructured":"Huang, X. Y. et al. Exosomal circRNA-100338 promotes hepatocellular carcinoma metastasis via enhancing invasiveness and angiogenesis. J. Exp. Clin. Cancer Res. 39, 20 (2020).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10618_CR24","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.4014\/jmb.2106.06031","volume":"31","author":"Y Bao","year":"2021","unstructured":"Bao, Y. et al. Hsa_Circ_0001947\/MiR-661\/DOK7 Axis restrains Non-Small cell lung Cancer development. J. Microbiol. Biotechnol. 31, 1508 (2021).","journal-title":"J. Microbiol. Biotechnol."},{"key":"10618_CR25","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.bbrc.2015.11.046","volume":"468","author":"Z Li","year":"2015","unstructured":"Li, Z., Liu, Y. H., Diao, H. Y., Ma, J. & Yao, Y. L. MiR-661 inhibits glioma cell proliferation, migration and invasion by targeting hTERT. Biochem. Biophys. Res. Commun. 468, 870 (2015).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10618_CR26","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1080\/15384101.2022.2072636","volume":"21","author":"X Lin","year":"2022","unstructured":"Lin, X., Zhong, L., Wang, N., Chu, X. & Liu, B. Hsa_circ_0103232 promotes melanoma cells proliferation and invasion via targeting miR-661\/RAB3D. CELL. CYCLE. 21, 1811 (2022).","journal-title":"CELL. CYCLE"},{"key":"10618_CR27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.biopha.2015.07.023","volume":"75","author":"T Zhu","year":"2015","unstructured":"Zhu, T. et al. MiR-661 contributed to cell proliferation of human ovarian cancer cells by repressing INPP5J expression. BIOMED. PHARMACOTHER. 75, 123 (2015).","journal-title":"BIOMED. PHARMACOTHER"},{"key":"10618_CR28","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2217\/bmm-2017-0273","volume":"12","author":"MA Ali","year":"2018","unstructured":"Ali, M. A. et al. Investigating miRNA-661 and ATG4-B mRNA expression as potential biomarkers for hepatocellular carcinoma. BIOMARK. MED. 12, 245 (2018).","journal-title":"BIOMARK. MED."},{"key":"10618_CR29","doi-asserted-by":"crossref","unstructured":"Matboli, M. et al. Impact of circ-0000221 in the Pathogenesis of Hepatocellular via Modulation of miR-661-PTPN11 mRNA Axis. PHARMACEUTICS 14 (2022).","DOI":"10.3390\/pharmaceutics14010138"},{"key":"10618_CR30","doi-asserted-by":"crossref","unstructured":"Ninomiya, K., Ohta, K., Yamashita, K., Mizuno, K. & Ohashi, K. PLEKHG4B enables actin cytoskeletal remodeling during epithelial cell-cell junction formation. J. CELL. SCI. 134, jcs249078 (2021).","DOI":"10.1242\/jcs.249078"},{"key":"10618_CR31","doi-asserted-by":"crossref","unstructured":"Lin, S. Y. et al. Recurrent HBV Integration Targets as Potential Drivers in Hepatocellular Carcinoma. CELLS-BASEL 10 (2021).","DOI":"10.3390\/cells10061294"},{"key":"10618_CR32","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","volume":"20","author":"LS Kristensen","year":"2019","unstructured":"Kristensen, L. S. et al. The biogenesis, biology and characterization of circular RNAs. NAT. REV. GENET. 20, 675 (2019).","journal-title":"NAT. REV. GENET."},{"key":"10618_CR33","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/s41418-019-0423-5","volume":"27","author":"W Zhao","year":"2020","unstructured":"Zhao, W. et al. Splicing factor derived circular RNA circUHRF1 accelerates oral squamous cell carcinoma tumorigenesis via feedback loop. CELL. DEATH DIFFER. 27, 919 (2020).","journal-title":"CELL. DEATH DIFFER."},{"key":"10618_CR34","doi-asserted-by":"publisher","first-page":"e994","DOI":"10.1002\/ctm2.994","volume":"12","author":"X Pan","year":"2022","unstructured":"Pan, X. et al. Circular RNA circ-TNPO3 inhibits clear cell renal cell carcinoma metastasis by binding to IGF2BP2 and destabilizing SERPINH1 mRNA. Clin. Transl Med. 12, e994 (2022).","journal-title":"Clin. Transl Med."},{"key":"10618_CR35","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12943-018-0914-x","volume":"17","author":"K Zeng","year":"2018","unstructured":"Zeng, K. et al. The pro-metastasis effect of circANKS1B in breast cancer. MOL. CANCER. 17, 160 (2018).","journal-title":"MOL. CANCER"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10618-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10618-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10618-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T01:44:37Z","timestamp":1757209477000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10618-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10618"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-10618-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"assertion":[{"value":"19 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Ethics Committee of The Third People\u2019s Hospital of Shenzhen. All experiments were performed in accordance with the ARRIVE guidelines. All experiments were performed in accordance with relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"24580"}}